Product DescriptionProduct description

1. Complies with the "Quality Management Standards for Centralized Intravenous Drug Compounding" and "USP800 Standards for Handling Hazardous Drugs";

2. Full-process monitoring and rapid traceability of the drug compounding process, enhancing hospital medication safety and reducing medical disputes related to drug compounding;

3. Compatible with vials and ampoules, adapting to more than 95% of anti-tumor chemotherapy drugs on the market;

4. Equipped with a patented drug compounding syringe that automatically balances the pressure difference inside and outside the vial, adapting to atmospheric pressure, negative pressure, positive pressure, and gas-generating drugs during compounding, preventing liquid splashing, and ensuring precise injection and aspiration;

5. Class 5 (Class 100) cleanliness in the compounding chamber, with a two-level compartment design, truly achieving separation of personnel and drugs during compounding, eliminating cross-infection, and enhancing occupational protection.

SpecificationsSpecifications

HT7 Main Technical Parameters

1. Dimensions: L 2710mm × W 1375mm × H 2450mm.

2. Weight: 2000KG.

3. Operating temperature range: -10℃~40℃.

4. Operating humidity range: ≤80%RH.

5. Operating noise: ≤68dB.

6. Applicable voltage range: Single-phase AC 220V±10% 50HZ.

7. Rated power: A2: 3.5kw, B2: 4.5kw.

8. Working chamber air purification: ISO Class 5 (Class 100).

9. Compounding speed: 120-180 vials/hour.

10. Working modes: single-group, multi-group drug compounding, precision medication compounding, shared medication compounding, combined medication compounding, and other compounding modes.